Skip to main content

Advertisement

Log in

Rheumatoid Arthritis

Clinical utility of the RAID (RA impact of disease) score

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

A new patient self-assessment tool shows promise as a simple measure of the overall impact of rheumatoid arthritis on a patient, but will it be able to gain the international acceptance required to become a clinical standard?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gossec, L. et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann. Rheum. Dis. 70, 935–942 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Boers, M. RAID: a valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials? Ann. Rheum. Dis. 70, 884–885 (2011).

    Article  PubMed  Google Scholar 

  3. Boers, M., Brooks, P., Strand, C. V. & Tugwell, P. The OMERACT filter for Outcome Measures in Rheumatology. J. Rheumatol. 25, 198–199 (1998).

    CAS  PubMed  Google Scholar 

  4. Bruce, B. & Fries, J. F. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual. Life Outcomes 1, 20 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Huskisson, E. C. Measurement of pain. Lancet 2, 1127–1131 (1974).

    Article  CAS  PubMed  Google Scholar 

  6. Houssien, D. A., Stucki, G. & Scott, D. L. A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology (Oxford) 38, 48–52 (1999).

    Article  CAS  Google Scholar 

  7. de Jong, Z., van der Heijde, D., McKenna, S. P. & Whalley, D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br. J. Rheumatol. 36, 878–883 (1997).

    Article  CAS  PubMed  Google Scholar 

  8. [No authors listed] EuroQol— a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16, 199–208 (1990).

  9. Tosh, J. C., Wailoo, A. J., Scott, D. L. & Deighton, C. M. Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J. Rheumatol. doi:10.3899/jrheum.101327.

  10. Scott, D. L., Khoshaba, B., Choy, E. H. & Kingsley, G. H. Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ. Ann. Rheum. Dis. 66, 1534–1537 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David L. Scott.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gullick, N., Scott, D. Clinical utility of the RAID (RA impact of disease) score. Nat Rev Rheumatol 7, 499–500 (2011). https://doi.org/10.1038/nrrheum.2011.105

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2011.105

  • Springer Nature Limited

This article is cited by

Navigation